DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Gianni L, Pienkowski T, Im YH. et al.
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.

Lancet Oncol 2012;
13: 25-32

Download Bibliographical Data

Access:
Access:
Access: